The Biotechnology Innovation Organization (BIO) announced this week that it has released new Principles on the Value of Biopharmaceuticals, which are the first of their kind. Read More »
Sanofi and Regeneron announced this week that the companies’ Phase 2 trial of dupilumab showed positive results in adult patients suffering from moderate-to-severe chronic sinusitis with nasal polyposis. Read More »
AmerisourceBergen Corp. announced this week a long-term agreement with Publix that will bring brand name, generic and over-the-counter products to the supermarket chain. Read More »
Livanta announced last week that it has agreed to the long-term use of InterQual to ensure and review the quality of care for Medicare beneficiaries, including short-stay patients. Read More »
Surescripts has released new data showing that New York currently leads the nation in the electronic prescribing of controlled substances (EPCS). Read More »
The National Community Pharmacists Association (NCPA) has proposed a variety of pro-patient and pro-pharmacist proposals to the U.S. Senate Finance Committee's Chronic Care Working Group. Read More »
Aetna announced this week that it will sign an accountable care organization agreement in accordance with the Delaware Valley Accountable Care Organization (DVACO). Read More »
MedNetOne Health Solutuions (MNOHS), which provides health-care management services, announced that it will be teaming up with Sav-Mor Drug Stores, based in Michigan. Read More »
The American Society of Health-System Pharmacists (ASHP) recently released its 2016 edition of the AHFS Drug Information (AHFS DI). Read More »
CVS Health announced this week that naloxone, an opioid overdose reversal medicine, would be made available in all CVS Pharmacies across Ohio and that a prescription would not be necessary for the purchase of the product. Read More »
Easton Pharmaceuticals, along with their partner, BMV Medica, announced this week that it has placed an initial order for the vaginal discharge diagnostic test, VS-Sense, and the amniotic fluid leak test, AmnioSense, from CommonSense, which manufactures the products in Israel. Read More »
ACADIA Pharmaceuticals announced last week that the Psychopharmacologic Drugs Advisory Committee, a committee that operates under the FDA, will review its New Drug Application (NDA) for NUPLAZID. Read More »
Bristol-Myers Squibb and Pfizer announced this week that the companies have agreed to a cooperative effort with Portola Pharmaceuticals to develop and commercialize andexanet alpha. Read More »
The American Journal of Pharmacy Benefits (AJPB) recently announced that it has officially launched its website, www.ajpb.com. Read More »
The U.S. Food and Drug Administration (FDA) has made a commitment to work on the backlogged list of generic drugs currently awaiting approval. Read More »
Merck announced this week that the Food and Drug Administration (FDA) has accepted its Biologics License Application for bezlotoxumab for review. Read More »
CVS Health Research Institute has released a study that shows substantial progress in specialty medication given to their patients who are enrolled in a pilot study that assesses Specialty Connect. Read More »
Pharmaceutical companies worldwide have joined together to appeal to governments to aid them in taking on what are called "superbugs." Read More »
AstraZeneca announced this week that its product Lynparza has been granted Breakthrough Therapy designation (BTD) by the U.S. Food and Drug Administration (FDA). Read More »
EMD Serono announced this week that Gary Zieziula has been named president and managing director of the biopharma company. Read More »
Alerts Sign-up
